PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Thursday, December 16. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Pri-Med has more virtual education planned. View the schedule here.

Plan Your CME/CE Experiences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Infectious Disease

COVID-19 Panel Discussion: December 2021 

Ty J. Gluckman, MD, FACC, FAHA | Charles Vega, MD, FAAFP | Daniel A. Solomon, MD

 

This pandemic required communication among specialists and primary care. In this COVID-19 panel, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community, Irvine, CA

Daniel A. Solomon, MD

Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital, Instructor of Medicine,, Harvard Medical School, Boston, MA

9:10–10:10am ET    CME/CE Accredited Session

Oncology

Early Action in HCC: Supporting the Patient Journey in Primary Care

Amit Singal, MD, MS | Ghassan Abou-Alfa, MD, MBA

 

Although hepatocellular carcinoma (HCC) screening can improve survival for patients, it is underused in clinical practice. Join two faculty experts as they discuss the urgency for early identification of HCC in primary care, and learn about the changing epidemiology of HCC and how primary care providers can support patients during their journey. This program also features patient/caregiver videos and interactive Q&A sessions.

Amit Singal, MD, MS

Professor of Medicine, Willis C. Maddrey Chair in Liver Disease, Chair of Hepatology, Medical Directory of Liver Tumor Program, UT Southwestern Medical Center, Dallas, TX

Ghassan Abou-Alfa, MD, MBA

Attending Physician, Memorial Sloan-Kettering Cancer Center, Professor of Medicine, Weill Medical College, Cornell University, New York, NY

Supported by an educational grant from Genentech, a member of the Roche Group

10:20–11:05am ET    Non-CME Industry Theater

Nephrology

Addressing Low Detection of Chronic Kidney Disease in At-Risk Patients

Jennifer Ennis, MD, FACP

 

Chronic kidney disease (CKD) screening and early detection helps improve patient outcomes; however only 4 out of 5 at-risk adult patients in the U.S. are being fully tested per recommended guidelines. Join Labcorp and the National Kidney Foundation (NKF) leaders as they discuss a study that supports testing at-risk patients, particularly those with diabetes and hypertension. Additionally, you will hear new recommendations from the NKF-American Society of Nephrology Task Force on re-assessing the inclusion of race in diagnosing CKD.


On this Webinar you will learn about:

  • The lack of testing for CKD among at-risk adults.
  • The importance of early detection for patients living with CKD.
  • How to address gaps in care and increase awareness about CKD risk factors.
  • Insights into task force recommendations on reassessing the inclusion of race in diagnosing CKD, in particular the impact to eGFR.
  • The new HEDIS® measure from the NKF & National Committee for Quality Assurance®.

Jennifer Ennis, MD, FACP

Medical Director, Clinical and Digital Solutions, Labcorp

Sponsored by Labcorp

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

COPD: What the Busy Clinician Needs to Know

Matthew Mintz, MD, FACP

 

This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.

Matthew Mintz, MD, FACP

Associate Clinical Professor of Medicine at, George Washington University School of Medicine & Health Sciences, Internal Medicine and Primary Care Physician,, Private Practice in Bethesda, Maryland

Sponsored by GlaxoSmithKline

11:15am–12:15pm ET    CME/CE Accredited Session

Gastroenterology

Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation

Philip Schoenfeld, MD, MSEd, MSc

 

This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..

12:25–1:25pm ET    CME/CE Accredited Session

Neurology

 

The entire field of migraine is witnessing a profound and unprecedented transformation with new therapeutic options now available to address serious unmet medical needs and patient burden. The new options range from monoclonal antibodies (mAbs) targeting the CGRP ligand or receptor for migraine prevention, to a selective serotonin agonist, to oral CGRP-targeting agents (gepants) now approved for both preventive and acute treatment. These new advances are creating a vitality and excitement in the field not seen since the advent of triptans more than 2 decades ago.

Stewart J. Tepper, MD, FAHS

Professor of Neurology, Geisel School of Medicine at Dartmouth, Director, Dartmouth Headache Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Merle Diamond, MD

Clinical Assistant Professor, Department of Medicine, Rosalind Franklin Universty of Medicine and Science/Chicago Medical School, President and Managing Director, Diamond Headache Clinic, Chicago, IL

Supported by Biohaven Pharmaceuticals

1:35–2:20pm ET    Non-CME Industry Theater

Rheumatology

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Christopher Parker, DO

 

  • Understand the causes and prevalence of chronic low back pain.
  • Differentiate inflammatory back pain (IBP) from mechanical back pain.
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.

Christopher Parker, DO

Sponsored by AbbVie

1:35–2:20pm ET    Non-CME Industry Theater

Infectious Disease

Treating Community-Acquired Bacterial Pneumonia (CABP): A Systemic Pleuromutilin Antibacterial in the Outpatient Setting

Christian Sandrock, MD, MPH, FCCP

 

Antimicrobial resistance, especially pneumococcal resistance to macrolide antibiotics, or potential safety concerns of commonly used antibiotics result in underserving certain patients with CABP.  A systemic pleuromutilin antibacterial may be a treatment alternative for these underserved patients.

Christian Sandrock, MD, MPH, FCCP

Director of Critical Care, UC Davis Health

Sponsored by Nabriva Therapeutics

2:30–3:30pm ET    CME/CE Accredited Session

Neurology

What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration

Richard S. Isaacson, MD | Katherine E. Galluzzi, DO, CMD, FACOFP

 

Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on.

This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.

Richard S. Isaacson, MD

Director, Center for Brain Health, Director, Alzheimer’s Prevention Clinic, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, Adjunct Associate Professor of Neurology, Department of Neurology, Weill Cornell Medicine/NewYork-Presbyterian, New York City, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Director, Comprehensive Care , Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Eisai

3:40–5:10pm ET    CME/CE Accredited Session

Hot Topics

Curbside Consults: Top Questions from PCPs on Diabetes, Atrial Fibrillation, and Geriatric Cancer Screening 

Martin J. Abrahamson, MD, FACP | Ty J. Gluckman, MD, FACC, FAHA | Lee A. Lindquist, MD, MPH, MBA

 

What do primary care providers need to know about diabetes, atrial fibrillation, and geriatric cancer screening? Join expert faculty as they review important questions they get asked about these topics! 

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine, Harvard Medical School, Director, Division of CME, Beth Israel Deaconess Medical Center, Boston, MA

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS) , Providence Heart Institute, Providence St. Joseph Health , Portland, OR

Lee A. Lindquist, MD, MPH, MBA

Chief of Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL

5:20–6:05pm ET    Non-CME Industry Theater

Pulmonology

Rethinking the Role of Nebulization in the Maintenance Treatment of COPD

Ryan D. Reber, DO

 

Join us to learn about a maintenance therapy for the treatment of COPD.

Ryan D. Reber, DO

Chief of Pulmonary and Critical Care Medicine, Medical Director, Intensive Care Unit , Paoli Hospital, Clinical Assistant Professor of Medicine, Sidney Kimmel Medical College of Thomas Jefferson University

Sponsored by Viatris and Theravance Biopharma